No products in the cart.
Return To ShopNo products in the cart.
Return To ShopCJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide designed to stimulate the secretion of growth hormone from the pituitary gland. Manufactured by Driada Medical, this compound is a popular choice among athletes and bodybuilders looking to enhance their performance and physique. The formulation includes a specific modification that extends its half-life, allowing for prolonged effects and fewer injections compared to traditional growth hormone-releasing peptides. The primary purpose of CJC-1295 with DAC is to increase endogenous growth hormone levels, leading to improved recovery, enhanced muscle growth, fat loss, and overall athletic performance.
With a concentration of 2 mg per vial, CJC-1295 is easy to handle, making it accessible for both seasoned users and newcomers alike. While this peptide is often used in therapeutic settings for conditions related to growth hormone deficiency, it has gained immense popularity in the sports community for its muscle-building and fat-loss capabilities.
CJC-1295 functions by mimicking the action of growth hormone-releasing hormone (GHRH), which signals the body to produce more growth hormone. This increase in growth hormone levels leads to several physiological benefits, including enhanced protein synthesis, which is crucial for muscle growth and repair.
The primary effects of CJC-1295 with DAC include:
1. Increased Muscle Mass: Users often report noticeable gains in muscle size and strength due to elevated growth hormone levels, which promote muscle fiber hypertrophy.
2. Enhanced Fat Loss: Growth hormone aids in lipolysis, the process of breaking down fats for energy, leading to better fat composition and leaner physique.
3. Improved Recovery Time: Increased growth hormone levels facilitate tissue repair, making recovery from intense training faster and more efficient.
4. Better Sleep Quality: Many users experience improved sleep patterns, which play a vital role in recovery and overall performance.
5. Boosted Immune Function: Higher growth hormone levels may enhance immune response, helping athletes stay healthy during intense training cycles.
Overall, the prolonged release and consistent levels achieved with CJC-1295 contribute to maximizing training efforts and muscle tone.
Obtaining CJC-1295 with DAC 2 mg from Driada Medical can be done through a simple and secure process. Here are the steps you should follow to ensure a smooth purchase experience:
Following these steps can help prevent potential issues and ensure you receive high-quality CJC-1295 with DAC.
CJC-1295 with DAC offers numerous benefits that make it appealing for athletes and fitness enthusiasts. Among the various advantages, the most notable include:
– Sustained Release: The DAC modification allows for prolonged effects with fewer injections, simplifying the administration process for users.
– Versatile Use: Ideal for bulking or cutting cycles, CJC-1295 can be integrated into various training regimens depending on individual goals.
– Enhanced Athletic Performance: Increased growth hormone levels improve endurance and strength, allowing athletes to train harder and longer.
– Minimal Side Effects: Compared to anabolic steroids or other performance enhancers, CJC-1295 generally has a favorable safety profile when used responsibly.
– Supports Longevity: Beyond physical performance, CJC-1295 may contribute to overall wellness, reducing the signs of aging and promoting longevity.
All these benefits contribute to the growing popularity of this peptide in sports pharmacology.
While CJC-1295 with DAC offers numerous benefits, there are important contraindications to consider. This peptide should not be used by individuals who are:
– Pregnant or nursing, as its safety in these populations has not been established.
– Individuals with existing hormonal disorders or pituitary gland issues, as use may exacerbate underlying conditions.
– Those with known allergies to any peptide components, as this may lead to adverse reactions.
– Below the age of 18, as hormone-level alterations may affect growth and development.
– Anyone currently undergoing treatment for cancer or with a history of malignancies, as the influence on growth factors could promote tumor growth.
Consultation with a healthcare professional is highly recommended before initiating any peptide therapy to ensure it aligns with individual health needs and circumstances.
| Active substance | Peptide |
|---|---|
| Release form | Vial |
| Water Retention | Moderate |
| Hepatotoxicity | None reported |
| Lab Test | Growth Hormone levels |
| Also known as | DAC:GRF, Drug Affinity Complex: Growth Hormone Releasing Factor |
| Blood pressure | No significant impact |
| Trade name | Not available under a specific trade name |
| Storage conditions | Should be refrigerated at 2-8 degrees Celsius, avoid freezing |
| Formula | C152H252N44O42 |
| Substance class | Peptide hormone |
| Main action | Increases plasma levels of growth hormone |
| Half-life | Approximately 6-8 days |
| Dosage (medical) | Typically 1-2 mg once or twice a week |
| Dosage (sports) | 1-2 mg two times a week |
| Effects | Increased muscle growth, enhanced fat loss, improved skin elasticity, strengthened immune system |
| Side effects | Irritation at injection site, water retention, tingling sensations, occasional dizziness |
| Use in sports | Used to enhance performance and accelerate recovery |
| Active ingredient, mg | 2 |
| Manufacturer | Driada Medical |
| Packing | Vial |
Copyright © 2026 cyclecorex.com
Select at least 2 products
to compare
Reviews
There are no reviews yet.